Loading…

Optimisation of CCL64-based bioassay for TGF-β

Transforming growth factor β (TGF-β) is released by a variety of cells and known to be involved in many different processes including the immune response, wound healing and carcinogenesis. As most experimental investigations have been based on quantitative analysis of TGF-β production using a bioass...

Full description

Saved in:
Bibliographic Details
Published in:Journal of immunological methods 1995-10, Vol.186 (2), p.267-274
Main Authors: Garrigue-Antar, Laure, Barbieux, Isabelle, Lieubeau, Blandine, Boisteau, Olivier, Grégoire, Marc
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transforming growth factor β (TGF-β) is released by a variety of cells and known to be involved in many different processes including the immune response, wound healing and carcinogenesis. As most experimental investigations have been based on quantitative analysis of TGF-β production using a bioassay, it seemed important to test the validity and limitations of this method. This paper analyses several parameters that may impair TGF-β quantification by bioassay. Recommendations are made concerning the influence of technical parameters and the presence of other cytokines (EGF and bFGF) commonly released by cultured cells to which the Mv1Lu mink lung epithelial cell line (CCL64) is sensitive.
ISSN:0022-1759
1872-7905
DOI:10.1016/0022-1759(95)00151-Y